Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind and Randomized Study to Determine the Safety and Tolerability of Multiple Doses of TP-102 in Subjects With Non-Infected and Infected Diabetic Foot Ulcers

NCT04803708 is registered in ClinicalTrials.gov with Technophage, SA as lead sponsor.

NCT NCT04803708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04803708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind and Randomized Study to Determine the Safety and Tolerability of Multiple Doses of TP-102 in Subjects With Non-Infected and Infected Diabetic Foot Ulcers
Lead sponsor
Technophage, SA
Phase
Phase 1/2
Overall status
Completed
Start date
March 22, 2021
Completion date
September 5, 2022
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acinetobacter infection, diabetic foot ulcer, pseudomonas aeruginosa infection, staphylococcus aureus infection